Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 6, 2011, Pages 1131-1145

  Permuth Wey, Jennifer ^a,b   Chen, Y Ann ^a   Tsai, Ya Yu ^a   Chen, Zhihua ^a   Qu, Xiaotao ^a   Lancaster, Johnathan M ^a   Stockwell, Heather ^b   Dagne, Getachew ^b   Iversen, Edwin ^d   Risch, Harvey ^e   Barnholtz Sloan, Jill ^f   Cunningham, Julie M ^g   Vierkant, Robert A ^g   Fridley, Brooke L ^g   Sutphen, Rebecca ^c   McLaughlin, John ^h   Narod, Steven A ⁱ   Goode, Ellen L ^g   Schildkraut, Joellen M ^d   Fenstermacher, David ^a   Phelan, Catherine M ^a   Sellers, Thomas A ^a   more..

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Mayo Clinic   (United States)

^h MOUNT SINAI HOSPITAL   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR NRF1;

ADULT; AGED; ARTICLE; BIOGENESIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MITOCHONDRIAL GENOME; MITOCHONDRION; MULTICENTER STUDY; OVARY CANCER; OVULATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID METABOLISM;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; DNA, MITOCHONDRIAL; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, MITOCHONDRIAL; GENOTYPE; HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NF-E2-RELATED FACTOR 2; NUCLEAR RESPIRATORY FACTOR 1; OVARIAN NEOPLASMS; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 79958024943     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1224     Document Type: Article

References (56)

1. American Cancer Society. Cancer Facts and Figures 2010. Atlanta: American Cancer Society; 2010.
2. Fathalla M. Incessant ovulation-a factor in ovarian neoplasia? Lancet Oncol 1971;2:163.
3. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21. (Pubitemid 14232385)
4. Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol 2009;472:413-37.
5. Desouki MM, Kulawiec M, Bansal S, Das GM, Singh KK. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther 2005;4:1367-73. (Pubitemid 43131182)
6. Karihtala P, Soini Y, Vaskivuo L, Bloigu R, Puistola U. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer 2009;19:1047-51.
7. Murdoch WJ. Ovulatory Factor in Ovarian Carcinogenesis. NY: Springer; 2008.
8. Roy D, Cai Q, Felty Q, Narayan S. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 2007;10:235-57. (Pubitemid 47057178)
9. Senthil K, Aranganathan S, Nalini N. Evidence of oxidative stress in the circulation of ovarian cancer patients. Clin Chim Acta 2004;339:27-32. (Pubitemid 37542454)
10. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010;38:96-109.
11. Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med 2007;7:121-31. (Pubitemid 46322283)
12. Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 2009;71:177-203.
13. Singh KK, Kulawiec M. Mitochondrial DNA polymorphism and risk of cancer. Methods Mol Biol 2009;471:291-303.
14. Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008;88:611-38. (Pubitemid 351520089)
15. Diaz F, Moraes CT. Mitochondrial biogenesis and turnover. Cell Calcium 2008;44:24-35.
16. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003;3:193-202. (Pubitemid 37328871)
17. Gavrilova-Jordan LP, Price TM. Actions of steroids in mitochondria. Semin Reprod Med 2007;25:154-64. (Pubitemid 46676902)
18. Klinge CM. Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem 2008;105:1342-51.
19. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 2007;67:4687-94. (Pubitemid 46910174)
20. Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin M, et al. North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 2006;175:468-72; discussion 472-3.
21. Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 2005;65:8028-33. (Pubitemid 41297284)
22. Liu VW, Wang Y, Yang HJ, Tsang PC, Ng TY, Wong LC, et al. Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum Mutat 2003;22:173-4. (Pubitemid 36950816)
23. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, et al. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1455-9. (Pubitemid 47076878)
24. Xu L, Hu Y, Chen B, Tang W, Han X, Yu H, et al. Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer 2006;16:1661-7. (Pubitemid 44060395)
25. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, et al. Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:3558-66.
26. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9. (Pubitemid 44141658)
27. Brandon MC, Lott MT, Nguyen KC, Spolim S, Navathe SB, Baldi P, et al. MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res 2005;33:D611-3.
28. Cotter D, Guda P, Fahy E, Subramaniam S. MitoProteome: mitochondrial protein sequence database and annotation system. Nucleic Acids Res 2004;32:D463-7.
29. Human Mitochondrial Protein Database. Available at: http://bioinfo. nist.gov/hmpd/Description.html. [accessed Jan 5 2010]
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75. Available at: http://pngu.mgh.harvard. edu/~purcell/plink/. [accessed Feb 3 2010] (Pubitemid 47330214)
31. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37:W600-5. Available at: http://manticore.niehs.nih.gov/.
32. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006;34:W635-41. Available at: http://fastsnp.ibms.sinica.edu/tw/.
33. Tung KH, Wilkens LR, Wu AH, McDuffie K, Nomura AM, Kolonel LN, et al. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 2005;161:321-9. (Pubitemid 40256203)
34. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
35. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34. (Pubitemid 34112296)
36. Fisher R. Statistical Methods for Research Workers. London: Oliver and Boyd; 1932.
37. Fridley BL, Jenkins G, Biernacka J. Self-contained gene-set analysis of expression data: an evaluation of existing and novel methods. PLoS ONE 2010;5:e12693. doi:10.1371/journal.pone.0012693.
38. Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, et al. Inherited determinants of ovarian cancer survival. Clin Cancer Res. 2010;16:995-1007.
39. Bellance N, Benard G, Furt F, Begueret H, Smolkova K, Passerieux E, et al. Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 2009;41:2566-77.
40. Formentini L, Martinez-Reyes I, Cuezva JM. The mitochondrial bioenergetic capacity of carcinomas. IUBMB Life 2010;62:554-60.
41. Lopez-Lluch G, Irusta PM, Navas P, de Cabo R. Mitochondrial biogenesis and healthy aging. Exp Gerontol 2008;43:813-9.
42. Venkatesh S, Kumar M, Sharma A, Kriplani A, Ammini AC, Talwar P, et al. Oxidative stress and ATPase6 mutation is associated with primary ovarian insufficiency. Arch Gynecol Obstet 2010;282:313-8.
43. Roberti M, Polosa PL, Bruni F, Manzari C, Deceglie S, Gadaleta MN, et al. The MTERF family proteins: mitochondrial transcription regulators and beyond. Biochim Biophys Acta 2009;1787:303-11.
44. Biswas M, Chan JY. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 2010;244:16-20.
45. Hu R, Saw CL, Yu R, Kong AN. Regulation of Nrf2 signaling for cancer chemoprevention: antioxidant coupled with anti-inflammatory. Antioxid Redox Signal 2010;13:1679-98.
46. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, et al. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc Natl Acad Sci U S A 2004;101:6472-7. (Pubitemid 38585998)
47. Luo H, Rankin GO, Liu L, Daddysman MK, Jiang BH, Chen YC. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer 2009;61:554-63.
48. Sun P, Sehouli J, Denkert C, Mustea A, Konsgen D, Koch I, et al. Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. J Mol Med 2005;83:457-67. (Pubitemid 40922168)
49. Davidson B, Hadar R, Stavnes HT, Trope CG, Reich R. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Hum Pathol 2009;40:705-13.
50. Lavalle CR, George KM, Sharlow ER, Lazo JS, Wipf P, Wang QJ. Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta 2010;1806:183-92.
51. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, et al. Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma. Cancer Causes Control 2009;20:47-55.
52. Gaillard S, Dwyer MA, McDonnell DP. Definition of the molecular basis for estrogen receptor-related eceptor-alpha-cofactor interactions. Mol Endocrinol 2007;21:62-76. (Pubitemid 46041691)
53. Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10:1375-403.
54. Stafford P, Chen-Quin EB. The pattern of natural selection in somatic cancer mutations of human mtDNA. J Hum Genet 2010;55:605-12.
55. Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F, et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 2009;3:171-81.
56. Schildkraut JM, Iversen ES, Wilson MA, Clyde MA, Moorman PG, Palmieri RT, et al. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. PLoS One 2010;5:e10061.